Early versus delayed treatment of relapsed ovarian cancer

Lancet. 2011 Jan 29;377(9763):380-1. doi: 10.1016/S0140-6736(11)60126-8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • CA-125 Antigen / blood
  • Drug Administration Schedule
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / drug therapy*

Substances

  • CA-125 Antigen